03.31.25 -- STREAM Edition: Advancing Pharma And MedTech: Innovations, Insights, Expertise

Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.

Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

Learn about the many advantages of partnering with UK-based CDMO Upperton Pharma Solutions, including their expertise and capabilities across oral solids and specialized nasal and pulmonary formulations.

Ponder the future of nucleic acid and nanoparticle-based therapeutics, including mRNA, CRISPR, and gene editing, as experts discuss innovative solutions for complex health challenges.

Ensure an mRNA's stability and effectiveness post-transcription with advanced filtration and chromatography techniques to enhance purity and recovery for superior therapeutics and vaccines.

Can you recall the fundamentals of outsourcing development and manufacturing five or 10 years ago, if you were in the industry then? Our panel can, and it’s instructive to take the trip back in time.

Uncover the key reasons why our partners trust us to produce safe, high-quality injectable pharmaceuticals, and discover where we are planning to head next.

Discover a solution with nearly 50 years of excellence in solid oral dose manufacturing and packaging that has innovative facilities and skilled professionals to deliver trusted products worldwide.

With cutting-edge innovations like smart glasses for live process insights and a data-sharing portal, we're able to provide the capacity and expertise to bring biologics to commercial success.

With a Ph.D. in bioanalytical chemistry from the University of Alaska Fairbanks, Kirschner brings nearly 15 years of experience in pharmaceutical development across biotech and CDMO sectors.